Kansas City, Kan- Kristin Crowley, an award-winning journalist, underwent a double mastectomy due to her family's history of breast cancer and the BRCA2 gene mutation. She shared her journey, highlighting her decision to proactively reduce her cancer risk by 90%. Dr. Jamie Wagner with The University of Kansas Cancer Center explained the BRCA2 mutation's impact, noting a 70% lifetime risk of breast cancer. Kristin's story underscores the importance of genetic testing and proactive health measures.
Kristin Crowley, patient
· Kristin shares her decision to undergo a double mastectomy due to her family history of breast cancer and the BRCA2 gene mutation.
· She explains how post-surgical pathology testing revealed she did have cancer. She’s grateful she had surgery despite pain complications which are now under control.
Dr. Jamie Wagner, Breast Surgical Oncologist, The University of Kansas Cancer Center
· Dr. Jamie Wagner explains the BRCA2 mutation and its impact on cancer risk, emphasizing the higher risk of developing breast cancer.
· She explains the pros and cons of mastectomy and high-risk screening, highlighting the significant risk reduction with mastectomy but the potential loss of breast sensation.
Therea Isabell, Nurse Navigator, The University of Kansas Cancer Center
· Theresa discusses her role in providing personalized care and support for patients with family histories of breast cancer.
· She explains patients have both a physical and emotional recovery from surgeries.
